Rapid ICH

by RapidAI  · Based in United States → — AI-powered clinical decision support for rapid stroke and neurovascular assessment.
Emergency Medicine Neurology Radiology

Contact for pricing
Regulatory Status Disclosed

Overview

Rapid ICH, part of the comprehensive RapidAI platform, is an artificial intelligence-powered software designed to quickly detect and triage suspected intracranial hemorrhage (ICH) on non-contrast computed tomography (NCCT) scans. It plays a crucial role in the acute assessment of patients presenting with neurological symptoms, particularly in stroke care. The software automatically processes images from a scanner, identifies various types of acute hemorrhages including intraparenchymal (IPH), intraventricular (IVH), subdural (SDH), and subarachnoid (SAH), and quantifies their volume, often down to 0.4 mL.

Rapid ICH provides immediate notifications to clinicians via PACS diagnostic workstations, email, and the Rapid Mobile app, streamlining workflow and accelerating critical treatment and transfer decisions. Developed using machine learning and deep learning techniques, it boasts high sensitivity and specificity for ICH detection, aiming to reduce missed hemorrhages and improve patient outcomes. The platform is designed to assist hospital networks and trained radiologists in workflow triage, complementing clinical judgment rather than replacing it.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Automated detection of suspected intracranial hemorrhage (ICH) on NCCT scans
  • Triage and rapid notification of suspected ICH cases
  • Detection of various hemorrhage subtypes (IPH, IVH, SDH, SAH)
  • Quantification of hemorrhage volume (down to 0.4 mL or 1 mL)
  • High sensitivity (e.g., 98.1-97%) and specificity (e.g., 99.7-100%) for ICH detection
  • Rapid image processing and notification (within minutes, often under 60 seconds)
  • Notifications delivered via PACS, email, and Rapid Mobile app
  • AI/Machine Learning powered analysis using convolutional neural networks
  • Prioritizes cases within the radiology worklist
  • Integration with the broader RapidAI platform for comprehensive stroke assessment

Use Cases

  • Expedited diagnosis of intracranial hemorrhage in acute neurological emergencies
  • Triage and prioritization of stroke patients in emergency departments and mobile stroke units
  • Assisting physicians in making timely treatment and transfer decisions for hemorrhagic stroke
  • Reducing the rate of missed hemorrhages in clinical routine
  • Streamlining workflow and communication for stroke care teams
  • Supporting Joint Commission ICH score compliance through automated volume measurement

What Physicians Need to Know

Stroke Detection Speed
Rapid ICH processes typical CT head scans in less than a minute, notifying clinicians of possible intracranial hemorrhage (ICH) in 3 minutes or less. Rapid LVO, a complementary module, can alert physicians to suspected large vessel occlusion (LVO) in as few as 3 minutes.
Brain MRI/CT Analysis
Rapid ICH analyzes non-contrast CT (NCCT) scans to detect all acute hemorrhage types, including intraparenchymal, intraventricular, subdural, and subarachnoid hemorrhages, with a sensitivity of 97% and specificity of 100% for ICH detection. It can quantify hemorrhage volume down to 1 mL. The RapidAI platform also offers modules for CT angiography (CTA), CT perfusion (CTP), and MRI analysis, as well as Rapid Hyperdensity for quantifying hyperdense regions, Rapid DeltaFuseu2122 for comparing serial CT scans, and Rapid MLS for assessing midline shift.
Large Vessel Occlusion Detection
RapidAI includes a dedicated module, Rapid LVO, for the detection of large vessel occlusion (LVO), demonstrating high sensitivity (90-98%) and specificity (82-94%). It identifies M1-MCA and intracranial ICA occlusions.
Triage Prioritization Speed
Rapid ICH is designed to triage and prioritize cases by flagging suspected ICH findings, processing CT head scans in under a minute. It prioritizes cases within the radiology worklist and significantly reduces turnaround time for newly identified hemorrhages.
ASPECTS Score Automation
RapidAI offers Rapid ASPECTS, an automated system that uses machine learning to score non-contrast CT scans based on the Alberta Stroke Program Early CT Score (ASPECTS). This helps identify early signs of brain infarction and assesses patient eligibility for thrombectomy, improving accuracy, especially for less experienced readers.
Mobile Notification System
Rapid ICH automatically sends notifications to PACS, email, and the Rapid mobile app immediately after processing. The Rapid Mobile App provides real-time alerts for new case events, allowing anytime, anywhere access to results, critical patient images, and facilitating communication among stroke teams.
Physician Tip

Rapid ICH offers rapid and accurate detection and quantification of various hemorrhage types, which is critical for timely intervention in acute stroke. Leveraging the automated ASPECTS scoring can standardize assessment of ischemic changes and aid in thrombectomy decisions, particularly beneficial for less experienced clinicians. Utilizing the comprehensive mobile notification system ensures immediate access to critical imaging results, facilitating faster treatment and transfer decisions and enhancing care coordination across multidisciplinary teams.

The RapidAI platform is designed for seamless integration with existing hospital systems, including PACS, EHRs, worklists, and reporting systems. It supports secure mobile, desktop, and workstation tools for care coordination. The platform also allows for integration with curated third-party AI algorithms to expand coverage across various service lines, with a notable integration with Pulsara for real-time team communication and image sharing.

Details

Category Neurology AI, Radiology & Imaging AI, Triage & ER/ICU AI
Pricing Contact for pricing — Enterprise pricing; contact vendor for details.
DeploymentOn-premise (dedicated or virtual servers) and secure cloud
Compliance
BAA AvailableUnknown AI-estimated
HIPAA Compliant Yes AI-estimated
FDA Status Yes AI-estimated

Rapid ICH is part of the Rapid NCCT Stroke platform, which received FDA 510(k) clearance (K221456) on September 12, 2022. It is cleared as a radiological computer-assisted triage and notification software for suspected intracranial hemorrhage (ICH) on non-enhanced head CT images.

Integrations
EHR Not specified
Specialties Emergency Medicine, Neurology, Radiology

What the Web Says

Rapid ICH, part of the RapidAI platform, is an AI-powered software designed to assist clinicians in the rapid detection and analysis of intracranial hemorrhage (ICH) from non-contrast CT scans in patients with suspected acute stroke. Physicians generally view it as a valuable tool that enhances stroke diagnosis and workflow efficiency by providing fast and accurate detection of ICH, often before images are even available in PACS. However, it is consistently emphasized that Rapid ICH is intended to complement, rather than replace, human interpretation of CT images.

Overall: Positive

Strengths

  • High sensitivity and specificity for ICH detection, with reported sensitivities between 92% and 97.84% and specificities between 95% and 99.52%.
  • Significantly reduces radiology-report turnaround time and critical case notification time, leading to faster clinical decision-making and potentially improved patient outcomes.
  • Aids in focusing interpretation to specific regions of anatomy for radiologists.
  • Provides volumetric quantification of intraparenchymal and intraventricular hemorrhages.
  • Notifies relevant medical personnel (ER physician, Radiologist, Neurologist) as soon as AI processing is complete.
  • User-friendly interface and cloud-based system.

Limitations

  • Low certainty of evidence regarding its impact on direct patient outcomes such as mortality, length of hospital stay, or health-related quality of life.
  • Susceptible to motion artifacts and may not perform well with poor contrast boluses for LVO detection (though this is for LVO, not specifically ICH).
  • Previous versions had a false-positive rate of approximately 5%, though newer versions aim to reduce this.
  • Does not detect ICHs smaller than 0.4 mL.
  • Requires oversight from physicians with neuroradiologic expertise to identify rare false-positives and negatives.
  • Cost-effectiveness of RapidAI for stroke detection is currently unknown.

Based on reviews from: NCBI Bookshelf, Reddit, Canadian Agency for Drugs and Technologies in Health, NeurologyLive, ResearchGate, Capterra, G2, Articsledge, American Journal of Neuroradiology, Trustpilot

Last updated: 2026-07-19

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate Rapid ICH

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money
No press coverage or publications on file yet. Know of some? Suggest an edit →

Videos

Product demos, reviews, and walkthroughs for Rapid ICH.

View all on YouTube

No FAQs available yet for this tool.

Related Tools

Cercare Medical Oncology Virtual Expert
Cercare Medical
Neurology AI
Cercare Medical's Oncology Virtual Expert is an AI-powered brain tumor segmentation module that provides fast, consistent, and semi-automated tumor analysis from standard MRI data, designed for on-premise deployment within existing clinical radiology workflows.
CoLumbo C-Spine
Smart Soft Healthcare AD
Clinical Decision Support & Reference
CoLumbo C-Spine is an AI-powered software that processes and analyzes cervical spine MRI exams, assisting clinicians in diagnosis and assessment.
MeRT System
Wave Neuroscience
Mental & Behavioral Health AI
MeRT (Magnetic e-Resonance Therapy) is an advanced, personalized form of TMS that uses your own brainwave data to guide treatment. It's a non-invasive, drug-free option designed to help the brain communicate more efficiently so symptoms of conditions like depression, anxiety, PTSD, TBI, autism, and more can improve.
Brainomix 360 Hyperdensity
Brainomix Limited
Neurology AI
Brainomix 360 Hyperdensity is an AI-powered neuroimaging software tool that detects and quantifies brain hyperdensities on CT scans, forming a crucial part of the Brainomix 360 Stroke platform for rapid and accurate stroke assessment.
SOMNUM
HoneyNaps
Clinical Decision Support & Reference
SOMNUM is an AI-enabled medical software tool by Honeynaps Co., Ltd. that provides comprehensive sleep analysis to aid in the diagnosis and management of sleep disorders.
DETECT-ME/CFS project
DETECT-ME/CFS project (ME/CFS Research Foundation)
Clinical Decision Support & Reference
The DETECT-ME/CFS project is developing an AI-supported clinical decision support system to improve the rapid and reliable diagnosis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

See all Neurology AI tools →

More from RapidAI

Rapid ASPECTS
RapidAI
Neurology AI
Rapid ASPECTS provides an automated, standardized ASPECTS score from non-contrast CT scans to quantify early ischemic changes and aid in determining thrombectomy eligibility for stroke patients.
Rapid Enterprise Platform
RapidAI
Cardiology AI
RapidAI's Enterprise Platform offers FDA-cleared, deep clinical AI solutions that connect imaging to clinical action across the health system, integrating with EHRs and PACS for enhanced decision-making and workflow efficiency.

View company profile →

Suggest an Edit → | Last Verified: 2026-04-18 | First Added: 2026-04-18
AI Tool Finder
AI-powered search. Results may not be comprehensive.